• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清素综合征、摇头丸(MDMA)及其他血清素能物质使用情况的定性综述:风险等级

Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.

作者信息

Silins Edmund, Copeland Jan, Dillon Paul

机构信息

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.

出版信息

Aust N Z J Psychiatry. 2007 Aug;41(8):649-55. doi: 10.1080/00048670701449237.

DOI:10.1080/00048670701449237
PMID:17620161
Abstract

Growth of the antidepressant market and widespread use of the illicit drug ecstasy (methylenedioxymethamphetamine; MDMA) creates a need to delineate the potential harms associated with the concomitant use of ecstasy and serotonergic pharmaceutical drugs. One such harm is serotonin syndrome. The study aimed to synthesize the risk of serotonin syndrome associated with the concomitant use of ecstasy and other serotonergic substances in a clinically relevant hierarchy for psychiatrists and other medical practitioners. An extensive online database search was carried out of the literature on serotonin syndrome, in relation to illicit drugs and simultaneous use of other substances. Numerous licit and illicit substances implicated in serotonin syndrome, when used with ecstasy, have potential for increased toxicity and are presented in a resulting hierarchy of risk. Substances that inhibit serotonin re-uptake are less likely to lead to life-threatening elevations in serotonin when used with ecstasy. High doses or repeated use of stimulants such as methamphetamine and cocaine with ecstasy increase the risk of serotonin syndrome; as does the use of pharmaceutical amphetamine and ecstasy. Serotonin precursors also influence the course of serotonin syndrome when used with ecstasy. Substances that inhibit monoamine oxidase are most likely to lead to serious increases in serotonin when used with ecstasy. Findings highlight the importance of screening for the use of ecstasy and other serotonergic substances when prescribing antidepressant drugs.

摘要

抗抑郁药市场的增长以及非法药物摇头丸(亚甲二氧基甲基苯丙胺;MDMA)的广泛使用,使得有必要明确同时使用摇头丸和血清素能药物可能带来的危害。其中一种危害就是血清素综合征。该研究旨在为精神科医生和其他医学从业者,在一个具有临床相关性的层级体系中,综合分析与同时使用摇头丸和其他血清素能物质相关的血清素综合征风险。针对与非法药物及其他物质同时使用相关的血清素综合征文献,进行了广泛的在线数据库搜索。许多与血清素综合征有关的合法和非法物质,在与摇头丸同时使用时,都有增加毒性的可能性,并在由此产生的风险层级中列出。与摇头丸同时使用时,抑制血清素再摄取的物质不太可能导致危及生命的血清素升高。高剂量或重复使用甲基苯丙胺和可卡因等兴奋剂与摇头丸会增加血清素综合征的风险;使用药用苯丙胺和摇头丸也是如此。血清素前体与摇头丸同时使用时也会影响血清素综合征的病程。与摇头丸同时使用时,抑制单胺氧化酶的物质最有可能导致血清素严重升高。研究结果凸显了在开具抗抑郁药物时筛查是否使用摇头丸和其他血清素能物质的重要性。

相似文献

1
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.血清素综合征、摇头丸(MDMA)及其他血清素能物质使用情况的定性综述:风险等级
Aust N Z J Psychiatry. 2007 Aug;41(8):649-55. doi: 10.1080/00048670701449237.
2
[3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].[3,4-亚甲基二氧甲基苯丙胺(“摇头丸”):其长期的情绪和认知影响以及血清素耗竭]
Rev Neurol. 2005;41(2):108-14.
3
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.摇头丸/MDMA 娱乐性使用者中多药滥用的混杂问题:简要概述。
J Psychopharmacol. 2006 Mar;20(2):188-93. doi: 10.1177/0269881106059939.
4
Recreational ecstasy use and depression.摇头丸的娱乐性使用与抑郁症
J Psychopharmacol. 2006 May;20(3):411-6. doi: 10.1177/0269881106063265.
5
Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.持续或停止使用多价摇头丸(摇头丸)的使用者的记忆表现。
Drug Alcohol Depend. 2005 Jun 1;78(3):317-23. doi: 10.1016/j.drugalcdep.2004.12.002. Epub 2005 Jan 19.
6
[Psychiatric and cognitive long-term effects of ecstasy].[摇头丸的精神和认知长期影响]
Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):596-8.
7
Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?使用娱乐性摇头丸(3,4-亚甲基二氧甲基苯丙胺)是否与更高水平的抑郁症状相关?
J Psychoactive Drugs. 2007 Mar;39(1):31-9. doi: 10.1080/02791072.2007.10399862.
8
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?亚甲二氧基苯丙胺(摇头丸)对人体的神经毒性:持续性脑损伤的证据有多确凿?
Addiction. 2006 Mar;101(3):348-61. doi: 10.1111/j.1360-0443.2006.01314.x.
9
A possible perianesthetic serotonin syndrome related to intrathecal fentanyl.一种可能与鞘内注射芬太尼相关的围麻醉期血清素综合征。
J Clin Anesth. 2008 Mar;20(2):143-5. doi: 10.1016/j.jclinane.2007.06.024.
10
The health effects of ecstasy: a literature review.摇头丸对健康的影响:文献综述。
Drug Alcohol Rev. 2002 Mar;21(1):53-63. doi: 10.1080/09595230220119363.

引用本文的文献

1
Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.迷幻药使用的保护性行为策略:证据综述
Psychedelic Med (New Rochelle). 2024 Dec 2;2(4):234-242. doi: 10.1089/psymed.2023.0052. eCollection 2024 Dec.
2
Predictors of Serotonin Syndrome in Acute Poisoning with 5-Hydroxytryptamine Modulators.5-羟色胺调节剂急性中毒中血清素综合征的预测因素
Toxics. 2024 Jul 30;12(8):550. doi: 10.3390/toxics12080550.
3
A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand.
新西兰关于迷幻药相关危害和危害减少经验与知识的主题分析。
Harm Reduct J. 2024 May 23;21(1):100. doi: 10.1186/s12954-024-01024-8.
4
Hot weather and death related to acute cocaine, opioid and amphetamine toxicity in British Columbia, Canada: a time-stratified case-crossover study.高温天气与加拿大不列颠哥伦比亚省急性可卡因、阿片类药物和苯丙胺类药物中毒相关死亡:时间分层病例交叉研究。
CMAJ Open. 2023 Jun 27;11(3):E569-E578. doi: 10.9778/cmajo.20210291. Print 2023 May-Jun.
5
Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors.与单胺氧化酶抑制剂的临床相关药物相互作用
Health Psychol Res. 2022 Nov 3;10(4):39576. doi: 10.52965/001c.39576. eCollection 2022.
6
Multimodal analgesic protocol for cervical disc replacement in the ambulatory setting: Clinical case series.门诊环境下颈椎间盘置换的多模式镇痛方案:临床病例系列
J Clin Orthop Trauma. 2022 Oct 22;35:102047. doi: 10.1016/j.jcot.2022.102047. eCollection 2022 Dec.
7
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.精神科药物与 MDMA 或裸盖菇素之间的药物相互作用:系统评价。
Psychopharmacology (Berl). 2022 Jun;239(6):1945-1976. doi: 10.1007/s00213-022-06083-y. Epub 2022 Mar 7.
8
Psychoactive substance use among students: A cross-sectional analysis.学生的精神活性物质使用情况:一项横断面分析。
Fundam Clin Pharmacol. 2022 Oct;36(5):908-914. doi: 10.1111/fcp.12771. Epub 2022 Mar 4.
9
Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database.FAERS数据库中报告的摇头丸使用者血清素综合征病例
Front Psychiatry. 2022 Jan 24;12:824288. doi: 10.3389/fpsyt.2021.824288. eCollection 2021.
10
The pharmacological interaction of compounds in ayahuasca: a systematic review.阿育吠陀中的化合物的药理学相互作用:系统评价。
Braz J Psychiatry. 2020 Nov-Dec;42(6):646-656. doi: 10.1590/1516-4446-2020-0884.